# Astigmatism-free 3D Optical Tweezer Control for Rapid Atom Rearrangement

Article · Yue-Hui Lu, Nathan Song, Tai Xiang, Jacquelyn Ho, Tsai-Chen Lee, Zhenjie Yan, Dan M. Stamper-Kurn

- Archive id: arxiv:2510.11451
- Published: 2025-10-13
- Venue: Optica Quantum 4, 241-249 (2026)
- DOI: https://doi.org/10.1364/opticaq.583554
- arXiv: https://arxiv.org/abs/2510.11451
- Citations: 4
- Source URL: https://arxiv.org/abs/2510.11451
- PDF: https://arxiv.org/pdf/2510.11451
- Provenance: arxiv

## Abstract

Reconfigurable neutral-atom arrays are a promising platform for quantum computing, quantum simulation, and quantum metrology, but atom transport using frequency-chirped acousto-optic deflectors (AODs) is limited by chirp-induced acoustic lensing and trajectory distortion. We address these limitations using a three-dimensional acousto-optic deflector lens (3D-AODL), a design predicted to reduce long-range transport times by more than a factor of two. We further introduce fading-Shepard waveforms that circumvent finite AOD bandwidth, enabling sustained axial displacement. We demonstrate unrestricted three-dimensional optical-tweezer motion over a 200 $μ$m $\\times$ 200 $μ$m $\\times$ 136 $μ$m volume with velocities exceeding 4.2 m/s. Arbitrary three-dimensional control of optical-tweezer trajectories enables rapid atom rearrangement and dynamical engineering of optical potentials in tweezer arrays and optical lattices. This capability advances quantum control and atom manipulation in neutral-atom quantum processors by enabling faster rearrangement, higher clock rates, and scalable sorting in complex geometries.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Neutral-Atom & Trapped-Ion Quantum Computing](https://space-kitty.com/topics/atoms-and-ions)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.